SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001086
Filing Date
2017-03-01
Accepted
2017-03-01 06:09:17
Documents
71
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231044z10-k.htm 10-K 1739596
2 EX-21.1 a2231044zex-21_1.htm EX-21.1 3278
3 EX-23.1 a2231044zex-23_1.htm EX-23.1 3843
4 EX-31.1 a2231044zex-31_1.htm EX-31.1 8117
5 EX-31.2 a2231044zex-31_2.htm EX-31.2 8105
6 EX-32 a2231044zex-32.htm EX-32 9438
13 G390832.JPG g390832.jpg GRAPHIC 100794
14 G358529.JPG g358529.jpg GRAPHIC 104990
  Complete submission text file 0001047469-17-001086.txt   10504214

Data Files

Seq Description Document Type Size
7 EX-101.INS tbph-20161231.xml EX-101.INS 2796024
8 EX-101.SCH tbph-20161231.xsd EX-101.SCH 65205
9 EX-101.CAL tbph-20161231_cal.xml EX-101.CAL 72362
10 EX-101.DEF tbph-20161231_def.xml EX-101.DEF 276235
11 EX-101.LAB tbph-20161231_lab.xml EX-101.LAB 668518
12 EX-101.PRE tbph-20161231_pre.xml EX-101.PRE 460399
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36033 | Film No.: 17651278
SIC: 2834 Pharmaceutical Preparations